Medicine and Dentistry
Breast Cancer
100%
Patient
88%
Neoplasm
32%
Recurrent Disease
16%
Therapeutic Procedure
14%
Neoadjuvant Chemotherapy
13%
Inpatient
13%
Hazard Ratio
12%
Axillary Lymph Node
12%
Overall Survival
12%
Gamma Urogastrone
11%
Surgery
11%
Magnetic Resonance Imaging
11%
Epidermal Growth Factor Receptor 2
11%
Sentinel Lymph Node Biopsy
11%
Breast
10%
Mastectomy
10%
Metastatic Carcinoma
10%
Triple Negative Breast Cancer
10%
Survival
10%
Recurrence Free Survival
9%
Radiation Therapy
9%
Hormone Receptor
9%
Chemotherapy
9%
Lymph Node Metastasis
8%
Tumor Infiltrating Lymphocyte
8%
Woman
8%
Positron Emission Tomography
7%
Malignant Neoplasm
6%
Age
6%
Intraductal Carcinoma
6%
Gene
6%
Tamoxifen
6%
Metastatic Breast Cancer
5%
Hormone Receptor
5%
Echography
5%
Quadrantectomy
5%
Nipple
5%
Lymph Node
5%
Analysis
5%
Shear Wave Elastography
5%
Standardized Uptake Value
5%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
32%
Chemotherapy
10%
Neoplasm
9%
Hormone Receptor
7%
Gamma Urogastrone
7%
Epidermal Growth Factor Receptor 2
7%
Recurrent Disease
6%
Recurrence Free Survival
6%
Overall Survival
5%
Biochemistry, Genetics and Molecular Biology
Nested Gene
10%
Mutation
10%
Protein
9%
Cancer Cell
8%
Magnetic Resonance Imaging
7%
Estrogen Receptor
6%
Positron Emission Tomography
5%
Epidermal Growth Factor Receptor
5%
Survival
5%